Focused on women’s health, the company has developed and commercialized prescription therapies addressing menopause and related conditions, including hormone replacement treatments. Its portfolio has included products such as Bijuva and Imvexxy, with commercialization and licensing arrangements shap...
No congressional trades have been disclosed for TherapeuticsMD (TXMD) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.